NCT06889753View on ClinicalTrials.gov

A Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women.

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Menopausal Women
Interventions
DIETARY_SUPPLEMENT

Graminex WSPE

Graminex Water Soluble Pollen Extract is standardized to 6% amino acids.

DIETARY_SUPPLEMENT

Graminex LSPE

Graminex Lipid Soluble Pollen Extract is standardized to 7% phytosterols.

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

N6B3L1

RECRUITING

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Graminex LLC

OTHER

NCT06889753 - A Clinical Trial to Investigate the Effect of Pollen Extracts on Menopausal Symptoms in Healthy Women. | Biotech Hunter | Biotech Hunter